A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00063726
Recruitment Status : Completed
First Posted : July 11, 2003
Last Update Posted : January 13, 2012
Information provided by:
Millennium Pharmaceuticals, Inc.